Adverse drug reaction monitoring during antimicrobial therapy for septicemia patients at a university hospital in New Delhi

Abstract

Background/AimsAdverse drug reaction (ADR) is an appreciably harmful or unpleasant reaction, resulting from an intervention related to the use of a medicinal product. The present study was conducted in order to monitor the frequency and severity of ADR during antimicrobial therapy of septicemia.MethodsA prospective, observational, and noncomparative study was conducted over a period of 6 months on patients of septicemia admitted at a university hospital. Naranjo algorithm scale was used for causality assessment. Severity assessment was done by Hartwig severity scale.ResultsADRs in selected hospitalized patients of septicemia was found to be in 26.5% of the study population. During the study period, 12 ADRs were confirmed occurring in 9, out of 34 admitted patients. Pediatric patients experienced maximum ADRs, 44.4%. Females experienced a significantly higher incidence of ADRs, 66.7%. According to Naranjo’s probability scale, 8.3% of ADRs were found to be definite, 58.3% as probable, and 33.3% as possible. A higher proportion of these ADRs, 66.7% were preventable in nature. Severity assessment showed that more than half of ADRs were moderate. Teicoplanin was found to be the commonest antimicrobial agent associated with ADRs, followed by gemifloxacin and ofloxacin.ConclusionsThe incidence and severity of ADRs observed in the present study was substantially high indicating the need of extra vigilant during the antimicrobial therapy of septicemia.

Present era of drug safety in India: An overview

“…Whereas, the noxious and unintended reactions observed at normal therapeutic dose are considered 'Adverse Drug Reactions' (ADRs). Furthermore, the "Adverse events" are the unfortunate events, which emerges during the drug treatment period and are not directly interlinked with the drug use (Alam et al, 2018).…”

Efficacy of graphene oxide-loaded cationic antimicrobial peptide AWRK6 on the neutralization of endotoxin activity and in the treatment of sepsis

“…To date, the treatment of sepsis, a disease of host immune disorders caused by bacterial infection, an array of therapeutic targets applied in clinical practice notwithstanding, still fails to yield an ideal outcome [1,2]. Endotoxin, also known as LPS, is an important component of the cell wall of Gram-negative bacteria and an essential inflammatory factor in the body [3].…”

Female Asthmatic Patients Have Higher Risk to Develop Gemifloxacin-Associated Skin Rash, Highlighting Unique Delayed Onset Characteristics

“…The proposed risk factors for Gemifloxacin-associated rash in Western countries include female gender, an age younger than 40 years, and postmenopausal women receiving hormone replacement therapy, but almost no reports focused in Asia exist [1,2,10,15,17]. A recent prospective study in India revealed that Gemifloxacin-induced skin rash was detected in one patient out of two prescriptions in septicemia patients [18].…”